SARTF (SARTF) Stock Price & Analysis
SARTF (SARTF) rose 4.30% to USD 227 as of June 10, 2026 at 02:19 UTC, according to Nexqual real-time market data.
SARTF last closed at USD 217.65; the session ranged USD 227–227 on volume of 1 shares. Market capitalization is $15.67B, with a 52-week range of USD 181.58–227 (PNK). Source: Nexqual, June 10, 2026 at 02:19 UTC.
Key Statistics (as of June 10, 2026 at 02:19 UTC)
| Price | USD 227 |
|---|---|
| Change | ▲ 4.30% (up) |
| Previous Close | USD 217.65 |
| Open | USD 227 |
| Day Range | USD 227 – 227 |
| 52-Week Range | USD 181.58 – 227 |
| Volume | 1 shares |
| Market Cap | $15.67B |
| Exchange | PNK |
Technical Analysis (SARTF)
Nexqual's technical model rates SARTF "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 02:19 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.84 (neutral) |
| vs SMA50 | Above (USD 218.47) |
| MACD | 0.51 (positive) |
Analyst Ratings (SARTF)
Wall Street analysts rate SARTF "None", per Nexqual as of June 10, 2026 at 02:19 UTC.
| Consensus Rating | None |
|---|
Earnings (SARTF)
| Next Earnings Date | 2026-07-23 |
|---|---|
| Revenue Estimate | $935.35M |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Financials & Fundamentals (SARTF)
| Total Revenue | $3.55B |
|---|---|
| Revenue Growth (YoY) | +1.80% |
| Gross Margin | +45.59% |
| Operating Margin | +17.11% |
| Profit Margin | +4.58% |
| ROE | +6.18% |
| Debt / Equity | 110.54 |
| Current Ratio | 0.91 |
| Total Cash | $573.80M |
| Total Debt | $4.30B |
| Free Cash Flow | $313.20M |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Financial Health Score (SARTF)
Nexqual rates SARTF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:19 UTC.
| Growth | Mixed — Revenue +4.7% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 17% |
| Balance Sheet | Weak — $574M cash vs $4.30B debt |
| Cash Flow | Solid — FCF $313M, 9% margin |
| Efficiency | Mixed — ROE 6%, ROA 3.7% |
Ownership (SARTF)
| Insider Ownership | +87.07% |
|---|---|
| Institutional Ownership | +1.92% |
| Shares Outstanding | 34.24M |
| Float | 27.45M |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Leadership (SARTF)
SARTF is led by Michael Grosse (age 58), CEO & Chairman of the Executive Board, per Nexqual as of June 10, 2026 at 02:19 UTC.
| CEO & Chairman of the Executive Board | Michael Grosse (age 58) |
|---|---|
| CFO & Member of Executive Board | Florian Funck Dipl.Kfm. (age 54) |
| President of Sartorius North America | Maurice Phelan |
| President of Environmental Technology Division | Theo Thijssen |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SDMHF | Sartorius Stedim Biotech | USD 212.25 | ▲ 0.59% |
| SUVPF | Sartorius AG | USD 233.92 | ▼ 18.84% |
| SAUHF | STRAUMANN HOLDING AG | USD 109 | ▼ 8.46% |
| TRUMY | Terumo Corp. | USD 14.17 | ▲ 1.07% |
| TRUMF | TERUMO CORP | USD 13.6 | ▼ 9.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:19 UTC. This page is informational and not investment advice.